Literature DB >> 20336751

Osteoconductivity of modified fluorcanasite glass-ceramics for bone tissue augmentation and repair.

S Bandyopadhyay-Ghosh1, P E P Faria, A Johnson, D N B Felipucci, I M Reaney, L A Salata, I M Brook, P V Hatton.   

Abstract

Modified fluorcanasite glasses were fabricated by either altering the molar ratios of Na(2)O and CaO or by adding P(2)O(5) to the parent stoichiometric glass compositions. Glasses were converted to glass-ceramics by a controlled two-stage heat treatment process. Rods (2 mm x 4 mm) were produced using the conventional lost-wax casting technique. Osteoconductive 45S5 bioglass was used as a reference material. Biocompatibility and osteoconductivity were investigated by implantation into healing defects (2 mm) in the midshaft of rabbit femora. Tissue response was investigated using conventional histology and scanning electron microscopy. Histological and histomorphometric evaluation of specimens after 12 weeks implantation showed significantly more bone contact with the surface of 45S5 bioglass implants when compared with other test materials. When the bone contact for each material was compared between experimental time points, the Glass-Ceramic 2 (CaO rich) group showed significant difference (p = 0.027) at 4 weeks, but no direct contact at 12 weeks. Histology and backscattered electron photomicrographs showed that modified fluorcanasite glass-ceramic implants had greater osteoconductivity than the parent stoichiometric composition. Of the new materials, fluorcanasite glass-ceramic implants modified by the addition of P(2)O(5) showed the greatest stimulation of new mineralized bone tissue formation adjacent to the implants after 4 and 12 weeks implantation. (c) 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336751     DOI: 10.1002/jbm.a.32750

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  3 in total

1.  Prediction of osteoconductive activity of modified potassium fluorrichterite glass-ceramics by immersion in simulated body fluid.

Authors:  Shashwat Bhakta; Deepak K Pattanayak; Hiroaki Takadama; Tadashi Kokubo; Cheryl A Miller; Mehdi Mirsaneh; Ian M Reaney; Ian Brook; Richard van Noort; Paul V Hatton
Journal:  J Mater Sci Mater Med       Date:  2010-08-20       Impact factor: 3.896

2.  In vitro biocompatibility of modified potassium fluorrichterite and potassium fluorrichterite-fluorapatite glass-ceramics.

Authors:  Shashwat Bhakta; Kathryn Hurrell Gillingham; Mehdi Mirsaneh; Cheryl A Miller; Ian M Reaney; Ian M Brook; Richard van Noort; Paul V Hatton
Journal:  J Mater Sci Mater Med       Date:  2011-06-25       Impact factor: 3.896

3.  Determination of relative in vivo osteoconductivity of modified potassium fluorrichterite glass-ceramics compared with 45S5 bioglass.

Authors:  Shashwat Bhakta; Paulo E Faira; Luiz A Salata; Patricio Jose de Oliveira Neto; Cheryl A Miller; Richard van Noort; Ian M Reaney; Ian M Brook; Paul V Hatton
Journal:  J Mater Sci Mater Med       Date:  2012-07-03       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.